Guiding Novel Neurologic Drug Approvals

The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.

Peripheral Arterial Disease From a Community Pharmacy Perspective

Peripheral arterial disease (PAD) describes a phenomenon in which circulation to the leg is diminished due to atherosclerosis, resulting in reduced blood flow and often causing pain that can be limiting to those who experience it. 

CMS Initiatives Regarding Pain-Management Issues

In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.

Worsening Overdose Crisis Predicted

Opioid-related research developments of interest to pharmacists.

Tylenol Cold & Flu Q&A

Quick Poll

How well is the Poll admin working for you?